SynthesisTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2015

The efficacy and safety of bevacizumab combined with chemotherapy in treatment of HER2-negative metastatic breast cancer: a meta-analysis based on published phase III trials.

Yuan Fang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.